Naloxone dosage for opioid reversal: current evidence and clinical implications

R Rzasa Lynn, JL Galinkin - Therapeutic advances in drug …, 2018 - journals.sagepub.com
Opioid-related mortality is a growing problem in the United States, and in 2015 there were
over 33,000 opioid-related deaths. To combat this mortality trend, naloxone is increasingly …

[HTML][HTML] Take-home naloxone for the emergency interim management of opioid overdose: the public health application of an emergency medicine

J Strang, R McDonald, G Campbell, L Degenhardt… - Drugs, 2019 - Springer
Naloxone is a well-established essential medicine for the treatment of life-threatening
heroin/opioid overdose in emergency medicine. Over two decades, the concept of 'take …

Naloxone in opioid poisoning: walking the tightrope

SFJ Clarke, PI Dargan, AL Jones - Emergency Medicine Journal, 2005 - emj.bmj.com
Acute opioid intoxication and overdose are common causes of presentation to emergency
departments. Although naloxone, a pure opioid antagonist, has been available for many …

Reducing the harm of opioid overdose with the safe use of naloxone: a pharmacologic review

HK Kim, LS Nelson - Expert opinion on drug safety, 2015 - Taylor & Francis
Introduction: Opioid overdose fatality has increased threefold since 1999. As a result,
prescription drug overdose surpassed motor vehicle collision as the leading cause of …

Carfentanil: a narrative review of its pharmacology and public health concerns

JLS Leen, DN Juurlink - Canadian Journal of Anesthesia, 2019 - search.proquest.com
Carfentanil is a synthetic fentanyl analogue approved for veterinary use. It is a mu-opioid
receptor agonist with an estimated analgesic potency approximately 10,000 times that of …

Opioids and anxiety

A Colasanti, EA Rabiner… - Journal of …, 2011 - journals.sagepub.com
The opioid system plays a crucial role in the neural modulation of anxiety. The involvement
of opioid ligands and receptors in physiological and dysfunctional forms of anxiety is …

[HTML][HTML] Deep brain stimulation of the periaqueductal gray releases endogenous opioids in humans

H Sims-Williams, JC Matthews, PS Talbot… - Neuroimage, 2017 - Elsevier
Deep brain stimulation (DBS) of the periaqueductal gray (PAG) is used in the treatment of
severe refractory neuropathic pain. We tested the hypothesis that DBS releases …

[HTML][HTML] Naloxone's dose-dependent displacement of [11C]carfentanil and duration of receptor occupancy in the rat brain

Y Kang, KA O'Conor, AC Kelleher, J Ramsey… - Scientific reports, 2022 - nature.com
The continuous rise in opioid overdoses in the United States is predominantly driven by very
potent synthetic opioids, mostly fentanyl and its derivatives (fentanyls). Although naloxone …

[HTML][HTML] The role of dynorphin and the kappa opioid receptor in the symptomatology of schizophrenia: a review of the evidence

SD Clark, A Abi-Dargham - Biological psychiatry, 2019 - Elsevier
Schizophrenia is a debilitating mental illness that affects approximately 1% of the world's
population. Despite much research in its neurobiology to aid in developing new treatments …

Target site occupancy: emerging generalizations from clinical and preclinical studies

S Grimwood, PR Hartig - Pharmacology & therapeutics, 2009 - Elsevier
What percentage of receptors, ion channels or transporters must be occupied by drugs to
trigger therapeutic effects in patients, or by drugs and other ligands to induce physiological …